Trisodium 1-amino-4-[[3-[[4-chloro-6-[(sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-2,4,6-trimethyl-5-sulphonatophenyl]amino]-9,10-dihydro-9,10-dioxoanthracene-2-sulphonate

Vapour pressure

Link to relevant study record(s)

Reference

Endpoint:

vapour pressure

Data waiving:

study technically not feasible

Justification for data waiving:

the study does not need to be conducted because the melting point is above 300°C

Description of key information

In accordance with Column 2 adaptation statement of REACH Annex VII, information requirement section 7.5, this study does not need to be conducted if the melting point is >300 °C. Thus, the determination of the melting point is considered negligible (0.000001 Pa assumed for risk assessment tool) and its numerical determination is not considered scientifically justified.

Key value for chemical safety assessment

Vapour pressure:

0 Pa

at the temperature of:

20 °C